Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872 is a clinical research site located in Indianapolis, Indiana, United States 46202-5116.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies.
Sponsors: AbbVie.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872 has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.